Related Experiment Videos
Data complement anti-STD activity of PRO 2000 gel. Contraceptives
AIDS Weekly Plus
|May 19, 1997
Summary
PRO 2000 topical microbicide gel demonstrated contraceptive efficacy in preclinical rabbit studies. Further research is planned to evaluate its potential for preventing HIV and STDs in women.
Area of Science:
- Reproductive Health
- Infectious Disease Prevention
- Topical Microbicides
Background:
- Lack of effective female-controlled barrier methods for HIV/STD prevention.
- PRO 2000 identified as a topical microbicide for women's health.
- HIV infections predominantly occur via heterosexual intercourse globally.
Purpose of the Study:
- To evaluate the contraceptive efficacy of PRO 2000 topical microbicide gel.
- To assess the potential for dual contraceptive and anti-HIV/STD applications.
- To present preclinical findings on PRO 2000's efficacy.
Main Methods:
- Preclinical in vitro and in vivo studies using rabbits.
- Intravaginal dosing with varying concentrations of PRO 2000 gel.
- Assessment of contraceptive effects on rabbit pregnancy rates.
- Evaluation of anti-HIV and anti-herpes simplex virus activity.
Main Results:
- PRO 2000 gel at 4% concentration showed contraceptive efficacy in rabbits.
- Lower concentrations did not significantly affect rabbit pregnancy rates.
- Both tested concentrations demonstrated prevention of HIV infection in preclinical tests.
- PRO 2000 blocked a wide range of HIV strains and herpes simplex virus.
Conclusions:
- PRO 2000 gel exhibits significant potential for women's health advancements.
- Contraceptive properties of PRO 2000 complement its anti-HIV/STD activity.
- Development of both contraceptive and non-contraceptive formulations is feasible.
- Clinical trials are underway to assess safety and efficacy in human populations.